EMD-640744

N/A

Report date: 2024/02/21 12:31:43

Base Information

Drug NameEMD-640744
Drug Alias NameSurvivin-expressing tumor vaccine (Survac)Survivin-expressing tumor vaccine (Merck KGaA)DPX-SurvivacSurvivin-expressing tumor vaccine (Immunovaccine)Survivin-expressing tumor vaccine (Merck Serono) +[9] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursFallopian Tube NeoplasmsOvarian Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesImmunovaccine Technologies IncBioVaxys Technology CorpUniversity Health Network (Uhn)
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms +[4] 
Inactive IndicationsSolid tumoursCarcinoma, Ovarian EpithelialNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A